PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-Jun-2022 Global Gene Synthesis Market Report to 2027 - Rising Efforts Toward Clinical Researches to Study Biological Systems is Driving Growth - ResearchAndMarkets.com Businesswire
01-Jun-2022 Global Anti-Inflammatory Drugs Market (2022 to 2027) - Featuring AbbVie, Amgen and Biogen Among Others - ResearchAndMarkets.com Businesswire
01-Jun-2022 InterVenn Biosciences Joins the WIN and FNIH Biomarker Consortiums to Introduce a Glycoproteomic Option for Liquid Biopsies Businesswire
01-Jun-2022 Surmodics to Present at Jefferies Healthcare Conference Businesswire
01-Jun-2022 Legend Biotech Reports First Quarter 2022 Financial Results and Recent Highlights Businesswire
01-Jun-2022 AVM Biotechnology to Present Poster Highlighting the Effects of AVM0703 Against Solid Tumors and Blood Cancers at the 2022 ASCO Annual Meeting Businesswire
01-Jun-2022 BDO’s BioProcess Technology Group to Present at the 2022 BIO International Convention Businesswire
01-Jun-2022 IACTA Pharmaceuticals to Present at Jefferies Healthcare Conference Businesswire
01-Jun-2022 Transcat Strengthens Central Region Presence with Acquisition of Alliance Calibration Businesswire
01-Jun-2022 Rallybio to Present at Upcoming Investor Conferences in June Businesswire
01-Jun-2022 GE Healthcare, Medtronic Partnership Accelerates Global Access to Personalized Care by Delivering Advanced Patient Monitoring Solutions on the CARESCAPE Platform Businesswire
01-Jun-2022 Global Oncology R&D Surges While Cancer Care Disruptions Ease, Says IQVIA Institute for Human Data Science Businesswire
01-Jun-2022 Agilent Releases IVDR-Compliant Instruments, Kits, and Reagents for Use in the European Union Businesswire
01-Jun-2022 Wugen to Participate in Upcoming June Investor Conferences Businesswire
01-Jun-2022 Moxe Health Raises $30M Series B to Further Advance Interoperability Businesswire
01-Jun-2022 Data Presented from the MIRROR Randomized Controlled Trial Demonstrate KRYSTEXXA® (pegloticase injection) Plus Methotrexate Resulted in Significant Improvement in Efficacy and Safety (Infusion Reactions) Compared to KRYSTEXXA Monotherapy Businesswire
01-Jun-2022 Amneal Launches LYVISPAH® (baclofen) for Spasticity Related to Multiple Sclerosis and Other Spinal Cord Disorders Businesswire
01-Jun-2022 Asher Bio Announces Clinical Trial Collaboration with Merck to Evaluate AB248 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors Businesswire
01-Jun-2022 Stoke Therapeutics to Present at the 2022 Jefferies Healthcare Conference Businesswire
01-Jun-2022 Artificial Intelligence in Drug Discovery Market Research Report 2022 - ResearchAndMarkets.com Businesswire